RATIONALE: Host antioxidant defense, consisting of enzymatic antioxidant activity and nonenzymatic antioxidant micronutrients, is implicated in asthma pathogenesis. Studies of antioxidant defense and adult incident asthma have either used measures of antioxidants estimated from questionnaires or not considered enzymatic aspects of host defense. OBJECTIVES: We conducted the first study designed and powered to investigate the association of antioxidant defenses on adult incident asthma. METHODS: In a nested case-control study, we followed Shanghai women (aged 40-70 years) without prevalent asthma at baseline, over 8 years. Subjects with incident asthma were ascertained prospectively by gold standard testing of symptomatic women and matched to two asymptomatic control subjects. MEASUREMENTS AND MAIN RESULTS: Baseline urinary F2-isoprostanes, plasma concentrations of antioxidant micronutrients (tocopherols, xanthines, carotenes, and lycopene), and antioxidant enzyme activity (platelet-activating factor acetylhydrolase [PAF-AH] and superoxide dismutase) were measured from samples collected before disease onset. Among 65,372 women, 150 (0.24%) developed asthma. F2-isoprostane levels before asthma onset were not different between cases and control subjects. Doubling of α-tocopherol concentrations and PAF-AH activity was associated with 50 and 37% decreased risk of incident asthma (α-tocopherol: adjusted odds ratio = 0.52; 95% confidence interval, 0.32-0.84; PAF-AH: adjusted odds ratio = 0.63; 95% confidence interval, 0.42-0.93). CONCLUSIONS: In this prospective study, α-tocopherol, within normal reference ranges, and PAF-AH enzymatic activity were associated with decreased asthma development. These modifiable risk factors may be an effective strategy to test for primary asthma prevention.
RATIONALE: Host antioxidant defense, consisting of enzymatic antioxidant activity and nonenzymatic antioxidant micronutrients, is implicated in asthma pathogenesis. Studies of antioxidant defense and adult incident asthma have either used measures of antioxidants estimated from questionnaires or not considered enzymatic aspects of host defense. OBJECTIVES: We conducted the first study designed and powered to investigate the association of antioxidant defenses on adult incident asthma. METHODS: In a nested case-control study, we followed Shanghai women (aged 40-70 years) without prevalent asthma at baseline, over 8 years. Subjects with incident asthma were ascertained prospectively by gold standard testing of symptomatic women and matched to two asymptomatic control subjects. MEASUREMENTS AND MAIN RESULTS: Baseline urinary F2-isoprostanes, plasma concentrations of antioxidant micronutrients (tocopherols, xanthines, carotenes, and lycopene), and antioxidant enzyme activity (platelet-activating factor acetylhydrolase [PAF-AH] and superoxide dismutase) were measured from samples collected before disease onset. Among 65,372 women, 150 (0.24%) developed asthma. F2-isoprostane levels before asthma onset were not different between cases and control subjects. Doubling of α-tocopherol concentrations and PAF-AH activity was associated with 50 and 37% decreased risk of incident asthma (α-tocopherol: adjusted odds ratio = 0.52; 95% confidence interval, 0.32-0.84; PAF-AH: adjusted odds ratio = 0.63; 95% confidence interval, 0.42-0.93). CONCLUSIONS: In this prospective study, α-tocopherol, within normal reference ranges, and PAF-AH enzymatic activity were associated with decreased asthma development. These modifiable risk factors may be an effective strategy to test for primary asthma prevention.
Authors: Lisa G Wood; Manohar L Garg; Robert J Blake; Sonia Garcia-Caraballo; Peter G Gibson Journal: J Am Coll Nutr Date: 2005-12 Impact factor: 3.169
Authors: B I Nwaru; S M Virtanen; G Alfthan; A M Karvonen; J Genuneit; R P Lauener; J-C Dalphin; A Hyvärinen; P Pfefferle; J Riedler; J Weber; C Roduit; V Kaulek; C Braun-Fahrländer; E von Mutius; J Pekkanen Journal: Allergy Date: 2013-11-11 Impact factor: 13.146
Authors: D M Stafforini; T Numao; A Tsodikov; D Vaitkus; T Fukuda; N Watanabe; N Fueki; T M McIntyre; G A Zimmerman; S Makino; S M Prescott Journal: J Clin Invest Date: 1999-04 Impact factor: 14.808
Authors: L M Kuitert; R M Angus; N C Barnes; P J Barnes; M F Bone; K F Chung; A J Fairfax; T W Higenbotham; B J O'Connor; B Piotrowska Journal: Am J Respir Crit Care Med Date: 1995-05 Impact factor: 21.405
Authors: Rohit Gaurav; Jason T Varasteh; Michael R Weaver; Sean R Jacobson; Laura Hernandez-Lagunas; Qing Liu; Eva Nozik-Grayck; Hong Wei Chu; Rafeul Alam; Børge G Nordestgaard; Camilla J Kobylecki; Shoaib Afzal; Geoffrey L Chupp; Russell P Bowler Journal: JCI Insight Date: 2017-09-07
Authors: Joan Cook-Mills; Tebeb Gebretsadik; Hiam Abdala-Valencia; Jeremy Green; Emma K Larkin; William D Dupont; Xiao Ou Shu; Myron Gross; Chunxue Bai; Yu-Tang Gao; Terryl J Hartman; Christian Rosas-Salazar; Tina Hartert Journal: Thorax Date: 2016-06-02 Impact factor: 9.139
Authors: Cosby A Stone; Joan Cook-Mills; Tebeb Gebretsadik; Christian Rosas-Salazar; Kedir Turi; Steven M Brunwasser; Alexandra Connolly; Patty Russell; Zhouwen Liu; Kaitlin Costello; Tina V Hartert Journal: J Pediatr Date: 2018-12-05 Impact factor: 6.314
Authors: Cosby A Stone; Cindy T McEvoy; Judy L Aschner; Ashudee Kirk; Christian Rosas-Salazar; Joan M Cook-Mills; Paul E Moore; William F Walsh; Tina V Hartert Journal: Neonatology Date: 2018-03-07 Impact factor: 5.106
Authors: Gregory J Smith; Joseph A Cichocki; Bennett J Doughty; Jose E Manautou; Sven-Eric Jordt; John B Morris Journal: Environ Health Perspect Date: 2015-10-09 Impact factor: 9.031